The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
Open accessAbstract
Introduction: To assess the role of the 21-gene recurrence score (RS) assay on decision-making of postoperative radiotherapy (RT) following breast-conserving surgery (BCS) in elderly women with early-stage breast cancer. Methods: The 21-gene RS for elderly (≥65 years) women with stage T1–2N0M0 estrogen receptor-positive breast cancer who underwent BCS from 2004 to 2015 was obtained from the Surveillance, Epidemiology, and End Results program. We estimated the association of 21-gene RS and adjuvant RT related to breast cancer-specific survival (BCSS) using propensity score matching (PSM). Results: We identified 18,456 patients, of which 15,326 (83.0%) received postoperative RT. Of identified patients, 58.9%, 34.0%, and 7.1% of patients had a low-, intermediate-, and high-risk RS, respectively. Receipt of postoperative RT was not related to the year of diagnosis according to the 21-gene RS groups. Multivariate analysis suggested that receipt of postoperative RT was an independent predictor of better BCSS before (hazard ratio [HR] 0.587, 95% confidence interval [CI] 0.426–0.809, P = 0.001) and after (HR 0.613, 95%CI 0.390–0.963, P = 0.034) PSM. However, subgroups analyses indicated that receipt of postoperative RT was related to better BCSS in women with intermediate-risk RS before (HR 0.467, 95%CI 0.283–0.772, P = 0.003) and after (HR 0.389, 95%CI 0.179–0.846, P = 0.017) PSM, but not in women with low- and high-risk RS groups before and after PSM. Conclusions: Although causation cannot be implied, adjuvant RT in elderly women was associated with a greater effect size in patients with an intermediate-risk RS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242 · cited 1×
“To reduce the potential confounding of retrospective studies, a 1:1 match including the variables mentioned above was conducted using propensity score matching (PSM) to create matched cohorts (17, 18).”
MethodA Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Rosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 4,774
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D. A., McCormick, B., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
Hughes, K. S., Schnaper, L. A., Berry, D., Cirrincione, C., McCormick, B., Shank, B., Wheeler, J., Champion, L. A., Smith, T. J., Smith, B. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040587 · Cited by 1,078
Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A., & Dixon, J. M. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71221-5 · Cited by 904
The impact of comorbidity on cancer and its treatment
Sarfati, D., Koczwara, B., & Jackson, C. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21342 · Cited by 680
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Mamounas, E. P., Tang, G., Fisher, B., Paik, S., Shak, S., Costantino, J. P., Watson, D., Geyer, C. E., Wickerham, D. L., & Wolmark, N. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7610 · Cited by 619
Biganzoli, L., Wildiers, H., Oakman, C., Marotti, L., Loibl, S., Kunkler, I., Reed, M., Ciatto, S., Voogd, A. C., Brain, E., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70383-7 · Cited by 567
Comparison of SEER Treatment Data With Medicare Claims
Noone, A.-M., Lund, J. L., Mariotto, A., Cronin, K., McNeel, T., Deapen, D., & Warren, J. L. (2016) · Medical Care · doi:10.1097/mlr.0000000000000073 · Cited by 488
Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach
Janssen-Heijnen, M. L. G., Houterman, S., Lemmens, V. E. P. P., Louwman, M. W. J., Maas, H. A. A. M., & Coebergh, J. W. W. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.04.008 · Cited by 379
Jagsi, R., Abrahamse, P., Hawley, S. T., Graff, J. J., Hamilton, A. S., & Katz, S. J. (2012) · Cancer · doi:10.1002/cncr.26295 · Cited by 191
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0060 · Cited by 183
Mamounas, E. P., Liu, Q., Paik, S., Baehner, F. L., Tang, G., Jeong, J., Kim, S. R., Butler, S. M., Jamshidian, F., Cherbavaz, D. B., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw259 · Cited by 129
Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer
Speers, C. W., & Pierce, L. J. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5805 · Cited by 117
Kyndi, M., Overgaard, M., Nielsen, H. M., Sørensen, F. B., Knudsen, H., & Overgaard, J. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.04.014 · Cited by 115
The effect of under-treatment of breast cancer in women 80 years of age and older
van Leeuwen, B. L., Rosenkranz, K. M., Feng, L., Bedrosian, I., Hartmann, K., Hunt, K. K., Kuerer, H. M., Ross, M. I., Singletary, S. E., & Babiera, G. V. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.05.010 · Cited by 81
Solin, L. J., Gray, R. J., Goldstein, L. J., Recht, A., Baehner, F. L., Shak, S., Badve, S., Perez, E. A., Shulman, L. N., Martino, S., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2072-y · Cited by 73
Wong, W. B., Ramsey, S. D., Barlow, W. E., Garrison, L. P., & Veenstra, D. L. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.08.006 · Cited by 48
Goodman, C. R., Seagle, B.-L. L., Kocherginsky, M., Donnelly, E. D., Shahabi, S., & Strauss, J. B. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3169 · Cited by 47
Nichol, A., Chan, E. K., Lucas, S. J., Smith, S. L., Gondara, L., Speers, C. H., & Tyldesley, S. K. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.094 · Cited by 36
Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
Herskovic, A., Wu, X., Christos, P. J., & Nagar, H. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.02.006 · Cited by 27
Towards an optimal multidisciplinary approach to breast cancer treatment for older women
Thavarajah, N., Menjak, I. B., Trudeau, M., Mehta, R., Wright, F., Leahey, A., Ellis, J., Gallagher, D., Moore, J., Bristow, B. J., et al. (2015) · Canadian Oncology Nursing Journal · doi:10.5737/23688076254384395 · Cited by 9
Cited by
McGrail, D. J., Pilié, P. G., Rashid, N. U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A. B., Lim, B., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.02.006 · Cited by 1,032
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S.-M. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 758
Magnetic nanoparticles in biomedical applications: A review
Materón, E. M., Miyazaki, C. M., Carr, O., Joshi, N., Picciani, P. H. S., Dalmaschio, C. J., Davis, F., & Shimizu, F. M. (2021) · Applied Surface Science Advances · doi:10.1016/j.apsadv.2021.100163 · Cited by 456
Chan, J. M., Quintanal-Villalonga, Á., Gao, V. R., Xie, Y., Allaj, V., Chaudhary, O., Masilionis, I., Egger, J., Chow, A., Walle, T., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.008 · Cited by 434
Self-citationDelivery technologies for in utero gene therapy
Palanki, R., Peranteau, W. H., & Mitchell, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.002 · Cited by 64
Metadata
- Authors
- Wu, S.-G., Zhang, W.-W., Wang, J., Dong, Y., Sun, J.-Y., Chen, Y.-X., & He, Z.-Y.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-01-29
- Volume
- 9
- Pages
- 1-1
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2911866893
- Cited by
- 359
- References
- 27
- FWCI
- 23.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.